Hypersensitivity of NIH3T3 cells transformed by H-ras gene to DNA-topoisomerase-I inhibitors

International Journal of Cancer

Volumn 67, Issue 5, 1996, Pages 702-708

  Ohira, Tatsuo ^a,b   Nishio, Kazuto ^a   Kanzawa, Fumihiko ^a   Ishida, Tomoyuki ^a   Ohe, Yuichiro ^a   Arioka, Hitoshi ^a   Funayama, Yasunori ^a   Ogasawara, Hayato ^a   Kato, Harubumi ^b   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A][PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; IRINOTECAN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; GROWTH INHIBITION; MOUSE; NONHUMAN; ONCOGENE C ERB; ONCOGENE H RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CAMPTOTHECIN; CELL LINE, TRANSFORMED; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; GENES, RAS; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; IMMUNOBLOTTING; MICE; PHOSPHORYLATION; RAS PROTEINS;

EID: 9544251502     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960904)67:5<702::AID-IJC19>3.0.CO;2-6     Document Type: Article

References (19)

1. AKINAGA, S., GOMI, K., MORIMOTO, M., TAMAOKI, T. and OKABE, M., Anti-tumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res., 51, 4888-4892 (1991).
2. BOS, J.L., ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689 (1989). (Erratum published in Cancer Res., 50, 1352 (1990).
3. D'ARPA, P., BEARDMORE, C. and LIU, L.F., Involvement of nucleic- acid synthesis in cell-killing mechanisms of topoisomerase poisons. Cancer Res., 50, 6919-6924 (1990).
4. DEFFIE, A.M., BATRA, J.K. and GOLDENBERG, G.J., Direct correlation between DNA topoisomerase-II activity and cytotoxicity in adriamycin- sensitive and -resistant P388 leukemia cell lines. Cancer Res., 49, 58-62 (1989).
5. FUKUOKA, M., NIITANI, H., SUZUKI, A., MOTOMIYA, M., HASEGAWA, K., NISHIWAKI, Y., KURIYAMA, T., ARIYOSHI, Y., NEGORO, S., MASUDA, N., NAKAJIMA, S. and TAGUCHI, T., A phase-II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J. clin. Oncol., 10, 16-20 (1992).
6. ISONISHI, S., HOM, D.K., THIEBAUT, F.B., MANN, S.C., ANDREWS, P.A., BASU, A., LAZO, J.S., EASTMAN, A. and HOWELL, S.B., Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. Cancer Res., 51, 5903-5909 (1991).
7. KANEDA, N., NAGATA, H., FURUTA, T. and YOKOKURA, T., Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. Cancer Res., 50, 1715-1720 (1990).
8. KINGSBURY, W.D., BOEHM, J.C., JAKAS, D.R., HOLDEN, K.G., HECHT, S.M., GALLAGHER, G., CARANFA, M.J., MCCABE, F.L., FAUCETTE, L.F., JOHNSON, R.K. and HERTZBERG, R.P., Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase-I and anti-tumor activity. J. med. Chem., 34, 98-107 (1991).
9. KOJIRI, K., KONDO, H., YOSHINARI, T., ARAKAWA, H., NAKAJIMA, S., SATOH, F., KAWAMURA, K., OKURA, A., SUDA, H. and OKANISHI, M., A new anti-tumor substance, BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity. J. Antibiotics, 44, 723-728 (1991).
10. LIU, L.F. and MILLER, K.G., Eukaryotic DNA topoisomerases: two forms of type-1 DNA topoisomerases from HeLa cell nuclei. Proc. nat. Acad. Sci. (Wash.), 78, 3487-3491 (1981).
11. MOSMANN, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. immunol. Methods, 65, 55-63 (1983).
12. NAMBI, P., WU, H.L., WOESSNER, R.D. and MATTERN, M.R., Inhibition of endothelin-mediated topoisomerase-I activation by pertussis toxin. FEBS Lett., 276, 17-20 (1990).
13. NIIMI, S., NAKAGAWA, K., YOKOTA, J., TSUNOKAWA, Y., NISHIO, K., TERASHIMA, Y., SHIBUYA, M., TERADA, M. and SAIJO, N., Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes. Brit. J. Cancer, 63, 237-241 (1991).
14. SAMUELS, D.S. and SHIMIZU, N., DNA-topoisomerase-I phosphorylation in murine fibroblasts treated with 12-O-tetradecanoylphorbol-13- acetate and in vitro by protein kinase. J. biol. Chem., 267, 11156-11162 (1992).
15. SHERO, J.H., BORDWELL, B., ROTHFIELD, N.F. and EARNSHAW, W.C., High titers of auto-antibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science, 231, 737-740 (1986).
16. SHINOHARA, N., OGISO, Y., KUZUMAKI, N., MULLAUER, L., KATABAMI, M., TOGASHI, M. and KOYANAGI, T., Circumvention of cisplatin resistance in H-ras-transformed NIH/3T3 cells by suppressor mutant of H-ras. Int. J. Oncol., 1, 93-96 (1992).
17. VOSBERG, H.P., DNA topoisomerases: enzymes that control DNA conformation. Curr. Topics Microbiol. Immunol., 114, 19-102 (1985).
18. YAMASHITA, Y., FUJII, N., MURAKATA, C., ASHIZAWA, T., OKABE, M. and NAKANO, H., Induction of mammalian DNA-topoisomerase-I- mediated DNA cleavage by anti-tumor indolocarbazole derivatives. Biochemistry, 31, 12069-12075 (1992).
19. YOSHINARI, T., MATSUMOTO, M., ARAKAWA, H., OKADA, H., NOGUCHI, K., SUDA, H., OKURA, A. and NISHIMURA, S., Novel anti-tumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H- indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase-I- mediated DNA cleavage and mechanisms of cell-line-selective cytotoxicity. Cancer Res., 55, 1310-1315 (1995).